MALAT1 was proven to act as a competing endogenous RNA (ceRNA) to facilitate the berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in post-stroke inflammation [48]. Here, MALAT1 is linked to stroke disorder.